The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion

Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology

Research output: Contribution to journalArticlepeer-review

Abstract

The value of preimplantation genetic testing for aneuploidy (PGT-A) as a screening test for in vitro fertilization (IVF) patients has yet to be determined. Several studies demonstrate higher birth rates after aneuploidy testing and elective single-embryo transfer (eSET), suggesting the potential for this testing to decrease the risk of multiple gestations, though these studies have important limitations. Earn online CME credit related to this document at www.asrm.org/elearn

Original languageEnglish (US)
Pages (from-to)429-436
Number of pages8
JournalFertility and sterility
Volume109
Issue number3
DOIs
StatePublished - Mar 2018

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion'. Together they form a unique fingerprint.

Cite this